Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.

Autor: Buchroithner J, Pichler J, Marosi C, Widhalm G, Seiz-Rosenhagen M, Novosielski M, Oberndorfer S, Ruckser R, Rössler K, Azizi A, von Campe G, Bordihn K, Felzmann T
Jazyk: angličtina
Zdroj: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2014 Jan; Vol. 52 (1), pp. 76-7.
DOI: 10.5414/CPXCES13EA02
Databáze: MEDLINE